That is about my understanding of it - The Genentech thing was always going to take (up to) 12 months for them to assess. If there is really something there then it will not take that long IMHO - thats just what is in the agreement I assume.
I don't think it means PYC is les interested in the current deal - just that we have completed our part of the deal and focussing on oncology now because that is the biggest potential - I think we will keep all the other stuff chugging along but it won't be a multipurpose discovery lab - it will be focussed on high probability commercial oncology targets. I haven't seen whats done but I am expecting the strategic review to focus direction and I assume the AGM is a good time to release that. Might be a fizzer - I am just assuming that is a good time to share the results of the review.
PYC Price at posting:
1.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)